For Donors and Investors
FAST is deeply invested in bringing promising interventions into current medical practice, as safely and quickly as possible—and we know scientists are not the only ones who will make this happen.
To this end, FAST is driving translational research and supporting the advancement of therapeutics for animal models to humans living with Angelman syndrome.
The goal is to advance as many promising therapeutic strategies as possible for Angelman syndrome, regardless of the obstacles, to find the best treatment options for our loved ones, for all ages and for all genotypes.
Supporting FAST’s mission can take many different forms.
Regardless of how you join this effort, you will help us continue our work to bring life-changing therapeutics to every individual living with Angelman syndrome. Our goal is to successfully complete this race—and no longer be necessary—by finding a cure.